Logotype for BridgeBio Pharma Inc

BridgeBio (BBIO) AGM 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for BridgeBio Pharma Inc

AGM 2026 summary

22 Jun, 2026

Opening remarks and agenda

  • Meeting commenced as an interactive webcast, following corporate bylaws and Delaware law.

  • Stockholders and guests were welcomed, and the agenda included reviewing and voting on proposals outlined in the proxy statement.

  • Voting procedures and rules of conduct were explained, with polls open during the meeting.

Board and executive committee updates

  • Directors and officers present were introduced, including the CEO, CFO, and other key executives.

  • Representatives from Deloitte (auditors), Goodwin Procter (outside counsel), and American Election Services (inspector of elections) attended.

Shareholder proposals

  • Five proposals were presented: election of three directors, advisory vote on executive compensation, advisory vote on frequency of compensation votes, ratification of Deloitte as auditor, and amendment to the stock option plan.

  • Board recommended approval of all proposals.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more